11 results
To provide high level of evidence that omitting perioperative antibiotic prophylaxis does not increase the postoperative infection rate, in patients with acute calculous cholecystitis undergoing laparoscopic cholecystectomy.
Current practice variation in selection of patients with gallbladder stones and abdominal complaints for cholecystectomy is not efficient. Here we evaluate stepwise selection for surgery to improve patient outcome and to reduce the number of…
To assess whether cholangiography using the Kumar clamp is faster and easier than using the Olsen catheter.
Primairy objective: To determine the diagnostic accuracy of MRI for the (differential) diagnosis of GB polyps and the differentiation between true and pseudo polyps in patients with suspected GB polyp(s) on previous imaging modality (TAUS) by using…
To demonstrate that primary LC as compared to PC is preferable with respect to morbidity and mortality in high risk surgical patients (APACHE-II score 7-14) with acute calculous cholecystitis.
The main objectives of this study are to evaluate the performance and ease of use of the Follow me mode of the AutoLap system during general and gynecological laparoscopic procedures.Study Procedures: No. & type. A total of 35 laparoscopic…
Evaluation of quality of life and resoration of function after bile duct injury.
To demonstrate that extended postoperative antibiotic treatment does not decrease the infectious complication rate in laparoscopic cholecystectomy for acute cholecystitis.
This study is designed to provide evidence regarding the prophylactic use of UDCA in preventing symptomatic gallstone disease after RYGB and Sleeve Gastrectomy.
The aim of this study is to explore the biological and microbial alterations after cholecystectomy that contribute to the pathophysiology of metabolic syndrome and metabolic dysfunction-associated steatotic liver disease (MASLD).
Primary:To evaluate the efficacy of 3 doses of RhuDex vs placebo for the treatment of PBC in patients with an inadequate response to UDCA.Secondary:• To identify efficacious RhuDex dose(s) for the treatment of PBC for further evaluation in phase III…